(Q39638390)

13 September 2017

title

A quantitative analysis of the costs and benefits of prostate cancer screening (English)

1 reference

prostate cancer screening

13 September 2017

1 reference

1 reference

R M Benoit

1

1 reference

13 September 2017

H Grönberg

series ordinal

2

1 reference

13 September 2017

M J Naslund

series ordinal

3

1 reference

13 September 2017

publication date

1 January 2001

1 reference

Prostate Cancer and Prostatic Diseases

13 September 2017

published in

1 reference

13 September 2017

volume

4

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

138-145

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500510

13 September 2017

exact match

0 references

cites work

A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Screening for prostate cancer. A decision analytic view

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

The palpable nodule of prostatic cancer. Results 15 years after radical excision

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Course of localized adenocarcinoma of the prostate treated by radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Patient age as a prognostic factor in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Perioperative and postoperative complications from bilateral pelvic lymphadenectomy and radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Mortality of patients after radical prostatectomy: analysis of recent Medicare claims

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

An economic rationale for prostate cancer screening

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Impact of anatomical radical prostatectomy on urinary continence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Patient-re ported complications and follow-up treatment after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Collagen implantation for post-prostatectomy incontinence: early experience with a transrectal ultrasonographically guided method.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Anastomotic strictures following radical prostatectomy: risk factors and management

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Impact of routine screening for adenocarcinoma of the prostate on stage distribution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Adenocarcinoma of the prostate: results of routine urological screening

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Questioning the value of screening for prostate cancer in asymptomatic men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Screening for prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Prostate cancer screening: current trends and future implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

The benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Screening for prostatic carcinoma with prostate specific antigen: results of the second year.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Long-term survival among men with conservatively treated localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Detection of latent prostate cancer from routine screening: comparison with breast cancer screening

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Clinical Stage B0 or T1c prostate cancer: nonpalpable disease identified by elevated serum prostate-specific antigen concentration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500510

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500510

1 reference

13 September 2017

1 reference